IMU Corporate Research, Innovation & Discovery

IMU Corporate

Research, Innovation & Discovery

Advancing Knowledge, Creating Impact

Research at IMU is driven by curiosity and anchored in purpose. Through interdisciplinary collaboration and strong partnerships, we translate ideas into action and discovery into impact – contributing to a more sustainable, equitable and resilient world. It is not an end, but a commitment to the future.

IMU researchers recognised globally

In 2024, 8 IMU researchers were on the Top 2% Scientists List (a ranking of the world’s most frequently cited researchers).

  • A/Prof Dinesh Kumar Chellappan, School of Pharmacy (SOP)
  • Prof Gerard George, School of Business and Technology (SOBT).
  • Prof Dr Hally Sreerama Reddy Chandrashekhar Thummala, School of Medicine (SOM)
  • Dr Katrina Chung Pooi Yin (SOM)
  • A/Prof Dr Nabil Eid Nabil Ahmed Saleh Eid (SOM)
  • A/Prof Pathiyil Ravi Shankar (SOM)
  • A/Prof Sajesh Kalkandi Veettil (SOP)
  • Prof Dato’ Dr Syed Mohamed Aljunid Bin Syed Junid (SOM)

Investing in the future

RM
0
mil
Total research funding in the past year (as of 31 December 2025)

Publications (as of 31 December 2025)

0
SCOPUS/WOS/ERA-indexed papers
0
%
of papers were published in Quartile 1 and 2 journals (based on WOS JCR 2024 list)

Key Pillar projects

We constantly move the needle in research and development – exploring, leading and supporting initiatives that bring impact to the community.

Creating meaningful, measurable impact

The IMUAXL Advanced Cell Laboratory, an Academia-Industry Nexus for Health Technology Advancement, is dedicated to driving breakthroughs in regenerative medicine, focusing on tissue repair, immune modulation, and innovative disease therapies.

Leading the way in brain science

IMU’s Brain Science Chair is dedicated to establishing national leadership in brain science, with a particular emphasis on neurodiversity in the Malaysian context.

Supporting national health

In partnership with the Ministry of Health (MOH), IMU supports national health through initiatives such as the SeDia Cohort study – the first large-scale cohort study on diabetes in Malaysia; and the establishment of the IMU-MOH Clinical Trial Unit (CTU) – one of the first university-MOH co-located CTUs in a public primary healthcare facility.